Market Scenario
Global Point-of-Care Testing Market (POC) was valued US$ 14Bn in 2017 and is anticipated to reach US$ 30Bn by 2026 at a CAGR of about 10.0% during a forecast.Global Point-of-Care Testing Market Global Point-of-Care (POC) Testing Market by product type, By Product Type, By End User and by region. Based on product type point of care market is segmented into Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Haematology Testing, Blood Gas Testing & Others. By End-User are segmented in Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals. Geographically into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
The driving factor for the point of care market is due to Rising in usage of home-based glucose monitoring systems, Coagulation Monitoring, Infectious Diseases Testing, in trending Pregnancy And Fertility Testing, developing technology and innovative launching scheme and best offers to eventually reduce public and national spending on health, These devices are being highly used for the rapid diagnosis of disease conditions for the early detection and management of the disease are the factor of growth in point of care market. High logistics costs and huge investment will be the restrains for point of care market.
Global Point-of-Care (POC) Testing Market is segmented into by product, by Product Type, by End-user Type, and by geography. In terms Product Type, Infectious Diseases Testing will be in higher demand due to rising Point-of-care diagnostic are offering various schemes such as ease of use in remote areas, technological advancements, and lowered price points, tests are used in finger stick or capillary samples will be the key factor to boost the point of care market. In End, User segment Home Care will be fastest growing department due to Growing concern for early-stage disease detection and to avoid the occurrence of any chronic condition is expected to drive the remote monitoring and raise demand for rapid tests are a growth opportunity in the point-of-care testing market.
Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period. The market growth in the region can be attributed to the emerging economies, increasing in disposal income, Large-scale rising population, changing lifestyle and early safety and precaution will lead the step in these regions to boost the point-of-care testing market in the Asia Pacific.
Abbott Laboratories, Akers Biosciences, Inc., Alfa Scientific Designs, Inc, Amnisure International, Arlington Scientific, Inc, Becton Dickinson (BD), Biotron Diagnostics, Inc, Boson Biotech Co. Ltd, Chembio Diagnostic Systems, Inc, DRG International, Inc, Daktari Diagnostics, Diasys Diagnostic Systems Gmbh, Diazyme Laboratories, Inc., EKF Diagnostics Holdings plc, Eurolyser Diagnostica Gmbh, Getein Biomedical, Inc,. Hema Diagnostic Systems, LLC, Jant Pharmacal Corporation, Nova Biomedical, Corp., Princeton Biomeditech Corporation, Teco Diagnostics, Wama Diagnostica.
Scope of Global Point-of-Care (POC) Testing Market
Global Point-of-Care (POC) Testing Market by Product Type:
• Glucose Monitoring
• Cardiac Markers
• Infectious Diseases Testing
• Cholesterol Testing
• Coagulation Monitoring
• Pregnancy and Fertility Testing
• Hematology Testing
• Blood Gas Testing
• Others
Global Point-of-Care (POC) Testing Market by End-User Type
• Clinics
• Home Care
• Laboratories
• Assisted living healthcare facilities
• Hospitals
Global Point-of-Care (POC) Testing Market by Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Key Player analyzed in the Report:
• Abbott
• Beckman Coulter Inc.
• Instrumentation Laboratory
• Johnson & Johnson
• Nova Biomedical
• Qiagen
• Roche Diagnostics Limited
• Siemens AG
• Abaxis, Inc.
• Abbott Laboratories
• Alfa Scientific Designs, Inc.
• ARKRAY, Inc.
• Ascencia Diabetes Care Holdings AG
• Becton Dickinson and Company
• bioMerieux SA
• CHEMBIO DIAGNOSTICS, INC.
• F. Hoffmann-La Roche AG
• LamdaGen Corporation
• Medtronic Public Limited Company
• Nova Biomedical
Table of Contents
Global Point-of-Care Testing Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Point-of-Care (POC) Testing Size, by Market Value (US$ Mn) and Market Volume (Units)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
4.8. Patent Registration
5. Supply Side and Demand Side Indicators
6. Global Point-of-Care (POC) Testing Market Analysis and Forecast
6.1. Global Point-of-Care (POC) Testing Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Point-of-Care (POC) Testing Market Analysis and Forecast, by Product
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Point-of-Care (POC) Testing Market Value Share Analysis, by Product
7.4. Global Point-of-Care (POC) Testing Market Size (US$ Mn) Forecast, by Product
7.5. Global Point-of-Care (POC) Testing Market Analysis, by Product
7.6. Global Point-of-Care (POC) Testing Market Attractiveness Analysis, by Product
8. Global Point-of-Care (POC) Testing Market Analysis and Forecast, by Application
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Point-of-Care (POC) Testing Market Value Share Analysis, by Application
8.4. Global Point-of-Care (POC) Testing Market Size (US$ Mn) Forecast, by Application
8.5. Global Point-of-Care (POC) Testing Market Analysis, by Application
8.6. Global Point-of-Care (POC) Testing Market Attractiveness Analysis, by Application
9. Global Point-of-Care (POC) Testing Market Analysis, by Region
9.1. Global Point-of-Care (POC) Testing Market Value Share Analysis, by Region
9.2. Global Point-of-Care (POC) Testing Market Size (US$ Mn) Forecast, by Region
9.3. Global Point-of-Care (POC) Testing Market Attractiveness Analysis, by Region
10. North America Point-of-Care (POC) Testing Market Analysis
10.1. Key Findings
10.2. North America Point-of-Care (POC) Testing Market Overview
10.3. North America Point-of-Care (POC) Testing Market Value Share Analysis, by Product
10.4. North America Point-of-Care (POC) Testing Market Forecast, by Product
10.4.1. Glucose Monitoring
10.4.2. Cardiac Markers
10.4.3. Infectious Diseases Testing
10.4.4. Cholesterol Testing
10.4.5. Coagulation Monitoring
10.4.6. Pregnancy And Fertility Testing
10.4.7. Hematology Testing
10.4.8. Blood Gas Testing
10.4.9. Others
10.5. North America Point-of-Care (POC) Testing Market Value Share Analysis, by Application
10.6. North America Point-of-Care (POC) Testing Market Forecast, by Application
10.6.1. Clinics
10.6.2. Home Care
10.6.3. Laboratories
10.6.4. Assisted living healthcare facilities
10.6.5. Hospitals
10.7. North America Point-of-Care (POC) Testing Market Value Share Analysis, by Country
10.8. North America Point-of-Care (POC) Testing Market Forecast, by Country
10.8.1. U.S.
10.8.2. Canada
10.9. North America Point-of-Care (POC) Testing Market Analysis, by Country
10.10. U.S. Point-of-Care (POC) Testing Market Forecast, by Product
10.10.1. Glucose Monitoring
10.10.2. Cardiac Markers
10.10.3. Infectious Diseases Testing
10.10.4. Cholesterol Testing
10.10.5. Coagulation Monitoring
10.10.6. Pregnancy And Fertility Testing
10.10.7. Hematology Testing
10.10.8. Blood Gas Testing
10.10.9. Others
10.11. U.S. Point-of-Care (POC) Testing Market Forecast, by Application
10.11.1. Clinics
10.11.2. Home Care
10.11.3. Laboratories
10.11.4. Assisted living healthcare facilities
10.11.5. Hospitals
10.12. Canada Point-of-Care (POC) Testing Market Forecast, by Product
10.12.1. Glucose Monitoring
10.12.2. Cardiac Markers
10.12.3. Infectious Diseases Testing
10.12.4. Cholesterol Testing
10.12.5. Coagulation Monitoring
10.12.6. Pregnancy And Fertility Testing
10.12.7. Hematology Testing
10.12.8. Blood Gas Testing
10.12.9. Others
10.13. Canada Point-of-Care (POC) Testing Market Forecast, by Application
10.13.1. Clinics
10.13.2. Home Care
10.13.3. Laboratories
10.13.4. Assisted living healthcare facilities
10.13.5. Hospitals
10.14. North America Point-of-Care (POC) Testing Market Attractiveness Analysis
10.14.1. By Product
10.14.2. By Application
10.15. PEST Analysis
10.16. Key Trends
10.17. Key Development
11. Europe Point-of-Care (POC) Testing Market Analysis
11.1. Key Findings
11.2. Europe Point-of-Care (POC) Testing Market Overview
11.3. Europe Point-of-Care (POC) Testing Market Value Share Analysis, by Product
11.4. Europe Point-of-Care (POC) Testing Market Forecast, by Product
11.4.1. Glucose Monitoring
11.4.2. Cardiac Markers
11.4.3. Infectious Diseases Testing
11.4.4. Cholesterol Testing
11.4.5. Coagulation Monitoring
11.4.6. Pregnancy And Fertility Testing
11.4.7. Hematology Testing
11.4.8. Blood Gas Testing
11.4.9. Others
11.5. Europe Point-of-Care (POC) Testing Market Value Share Analysis, by Application
11.6. Europe Point-of-Care (POC) Testing Market Forecast, by Application
11.6.1. Clinics
11.6.2. Home Care
11.6.3. Laboratories
11.6.4. Assisted living healthcare facilities
11.6.5. Hospitals
11.6.6. Europe Point-of-Care (POC) Testing Market Value Share Analysis, by Country
11.7. Europe Point-of-Care (POC) Testing Market Forecast, by Country
11.7.1. Germany
11.7.2. U.K.
11.7.3. France
11.7.4. Italy
11.7.5. Spain
11.7.6. Rest of Europe
11.8. Europe Point-of-Care (POC) Testing Market Analysis, by Country
11.9. Germany Point-of-Care (POC) Testing Market Forecast, by Product
11.9.1. Glucose Monitoring
11.9.2. Cardiac Markers
11.9.3. Infectious Diseases Testing
11.9.4. Cholesterol Testing
11.9.5. Coagulation Monitoring
11.9.6. Pregnancy And Fertility Testing
11.9.7. Hematology Testing
11.9.8. Blood Gas Testing
11.9.9. Others
11.10. Germany Point-of-Care (POC) Testing Market Forecast, by Application
11.10.1. Clinics
11.10.2. Home Care
11.10.3. Laboratories
11.10.4. Assisted living healthcare facilities
11.10.5. Hospitals
11.11. U.K. Point-of-Care (POC) Testing Market Forecast, by Product
11.11.1. Glucose Monitoring
11.11.2. Cardiac Markers
11.11.3. Infectious Diseases Testing
11.11.4. Cholesterol Testing
11.11.5. Coagulation Monitoring
11.11.6. Pregnancy And Fertility Testing
11.11.7. Hematology Testing
11.11.8. Blood Gas Testing
11.11.9. Others
11.12. U.K. Point-of-Care (POC) Testing Market Forecast, by Application
11.12.1. Clinics
11.12.2. Home Care
11.12.3. Laboratories
11.12.4. Assisted living healthcare facilities
11.12.5. Hospitals
11.13. France Point-of-Care (POC) Testing Market Forecast, by Product
11.13.1. Glucose Monitoring
11.13.2. Cardiac Markers
11.13.3. Infectious Diseases Testing
11.13.4. Cholesterol Testing
11.13.5. Coagulation Monitoring
11.13.6. Pregnancy And Fertility Testing
11.13.7. Hematology Testing
11.13.8. Blood Gas Testing
11.13.9. Others
11.14. France Point-of-Care (POC) Testing Market Forecast, by Application
11.14.1. Clinics
11.14.2. Home Care
11.14.3. Laboratories
11.14.4. Assisted living healthcare facilities
11.14.5. Hospitals
11.15. Italy Point-of-Care (POC) Testing Market Forecast, by Product
11.15.1. Glucose Monitoring
11.15.2. Cardiac Markers
11.15.3. Infectious Diseases Testing
11.15.4. Cholesterol Testing
11.15.5. Coagulation Monitoring
11.15.6. Pregnancy And Fertility Testing
11.15.7. Hematology Testing
11.15.8. Blood Gas Testing
11.15.9. Others
11.16. Italy Point-of-Care (POC) Testing Market Forecast, by Application
11.16.1. Clinics
11.16.2. Home Care
11.16.3. Laboratories
11.16.4. Assisted living healthcare facilities
11.16.5. Hospitals
11.17. Spain Point-of-Care (POC) Testing Market Forecast, by Product
11.17.1. Glucose Monitoring
11.17.2. Cardiac Markers
11.17.3. Infectious Diseases Testing
11.17.4. Cholesterol Testing
11.17.5. Coagulation Monitoring
11.17.6. Pregnancy And Fertility Testing
11.17.7. Hematology Testing
11.17.8. Blood Gas Testing
11.17.9. Others
11.18. Spain Point-of-Care (POC) Testing Market Forecast, by Application
11.18.1. Clinics
11.18.2. Home Care
11.18.3. Laboratories
11.18.4. Assisted living healthcare facilities
11.18.5. Hospitals
11.19. Rest of Europe Point-of-Care (POC) Testing Market Forecast, by Product
11.19.1. Glucose Monitoring
11.19.2. Cardiac Markers
11.19.3. Infectious Diseases Testing
11.19.4. Cholesterol Testing
11.19.5. Coagulation Monitoring
11.19.6. Pregnancy And Fertility Testing
11.19.7. Hematology Testing
11.19.8. Blood Gas Testing
11.19.9. Others
11.20. Rest of Europe Point-of-Care (POC) Testing Market Forecast, by Application
11.20.1. Clinics
11.20.2. Home Care
11.20.3. Laboratories
11.20.4. Assisted living healthcare facilities
11.20.5. Hospitals
11.21. Europe Point-of-Care (POC) Testing Market Attractiveness Analysis
11.21.1. By Product
11.21.2. By Application
11.22. PEST Analysis
11.23. Key Trend
11.24. Key Development
12. Asia Pacific Point-of-Care (POC) Testing Market Analysis
12.1. Key Findings
12.2. Asia Pacific Point-of-Care (POC) Testing Market Overview
12.3. Asia Pacific Point-of-Care (POC) Testing Market Value Share Analysis, by Product
12.4. Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Product
12.4.1. Glucose Monitoring
12.4.2. Cardiac Markers
12.4.3. Infectious Diseases Testing
12.4.4. Cholesterol Testing
12.4.5. Coagulation Monitoring
12.4.6. Pregnancy And Fertility Testing
12.4.7. Hematology Testing
12.4.8. Blood Gas Testing
12.4.9. Others
12.5. Asia Pacific Point-of-Care (POC) Testing Market Value Share Analysis, by Application
12.6. Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Application
12.6.1. Clinics
12.6.2. Home Care
12.6.3. Laboratories
12.6.4. Assisted living healthcare facilities
12.6.5. Hospitals
12.7. Asia Pacific Point-of-Care (POC) Testing Market Value Share Analysis, by Country
12.8. Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Country
12.8.1. China
12.8.2. India
12.8.3. Japan
12.8.4. ASEAN
12.8.5. Rest of Asia Pacific
12.9. Asia Pacific Point-of-Care (POC) Testing Market Analysis, by Country
12.10. China Point-of-Care (POC) Testing Market Forecast, by Product
12.10.1. Glucose Monitoring
12.10.2. Cardiac Markers
12.10.3. Infectious Diseases Testing
12.10.4. Cholesterol Testing
12.10.5. Coagulation Monitoring
12.10.6. Pregnancy And Fertility Testing
12.10.7. Hematology Testing
12.10.8. Blood Gas Testing
12.10.9. Others
12.11. China Point-of-Care (POC) Testing Market Forecast, by Application
12.11.1. Clinics
12.11.2. Home Care
12.11.3. Laboratories
12.11.4. Assisted living healthcare facilities
12.11.5. Hospitals
12.12. India Point-of-Care (POC) Testing Market Forecast, by Product
12.12.1. Glucose Monitoring
12.12.2. Cardiac Markers
12.12.3. Infectious Diseases Testing
12.12.4. Cholesterol Testing
12.12.5. Coagulation Monitoring
12.12.6. Pregnancy And Fertility Testing
12.12.7. Hematology Testing
12.12.8. Blood Gas Testing
12.12.9. Others
12.13. India Point-of-Care (POC) Testing Market Forecast, by Application
12.13.1. Clinics
12.13.2. Home Care
12.13.3. Laboratories
12.13.4. Assisted living healthcare facilities
12.13.5. Hospitals
12.14. Japan Point-of-Care (POC) Testing Market Forecast, by Product
12.14.1. Glucose Monitoring
12.14.2. Cardiac Markers
12.14.3. Infectious Diseases Testing
12.14.4. Cholesterol Testing
12.14.5. Coagulation Monitoring
12.14.6. Pregnancy And Fertility Testing
12.14.7. Hematology Testing
12.14.8. Blood Gas Testing
12.14.9. Others
12.15. Japan Point-of-Care (POC) Testing Market Forecast, by Application
12.15.1. Clinics
12.15.2. Home Care
12.15.3. Laboratories
12.15.4. Assisted living healthcare facilities
12.15.5. Hospitals
12.16. ASEAN Point-of-Care (POC) Testing Market Forecast, by Product
12.16.1. Glucose Monitoring
12.16.2. Cardiac Markers
12.16.3. Infectious Diseases Testing
12.16.4. Cholesterol Testing
12.16.5. Coagulation Monitoring
12.16.6. Pregnancy And Fertility Testing
12.16.7. Hematology Testing
12.16.8. Blood Gas Testing
12.16.9. Others
12.17. ASEAN Point-of-Care (POC) Testing Market Forecast, by Application
12.17.1. Clinics
12.17.2. Home Care
12.17.3. Laboratories
12.17.4. Assisted living healthcare facilities
12.17.5. Hospitals
12.18. Rest of Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Product
12.18.1. Glucose Monitoring
12.18.2. Cardiac Markers
12.18.3. Infectious Diseases Testing
12.18.4. Cholesterol Testing
12.18.5. Coagulation Monitoring
12.18.6. Pregnancy And Fertility Testing
12.18.7. Hematology Testing
12.18.8. Blood Gas Testing
12.18.9. Others
12.19. Rest of Asia Pacific Point-of-Care (POC) Testing Market Forecast, by Application
12.19.1. Clinics
12.19.2. Home Care
12.19.3. Laboratories
12.19.4. Assisted living healthcare facilities
12.19.5. Hospitals
12.20. Asia Pacific Point-of-Care (POC) Testing Market Attractiveness Analysis
12.20.1. By Product
12.20.2. By Application
12.21. PEST Analysis
12.22. Key Trend
12.23. Key Development
13. Middle East & Africa Point-of-Care (POC) Testing Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Point-of-Care (POC) Testing Market Overview
13.3. Middle East & Africa Point-of-Care (POC) Testing Market Value Share Analysis, by Product
13.4. Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Product
13.4.1. Glucose Monitoring
13.4.2. Cardiac Markers
13.4.3. Infectious Diseases Testing
13.4.4. Cholesterol Testing
13.4.5. Coagulation Monitoring
13.4.6. Pregnancy And Fertility Testing
13.4.7. Hematology Testing
13.4.8. Blood Gas Testing
13.4.9. Others
13.5. Middle East & Africa Point-of-Care (POC) Testing Market Value Share Analysis, by Application
13.6. Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Application
13.6.1. Clinics
13.6.2. Home Care
13.6.3. Laboratories
13.6.4. Assisted living healthcare facilities
13.6.5. Hospitals
13.7. Middle East & Africa Point-of-Care (POC) Testing Market Value Share Analysis, by Country
13.8. Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Country
13.8.1. GCC
13.8.2. South Africa
13.8.3. Rest of Middle East & Africa
13.9. Middle East & Africa Point-of-Care (POC) Testing Market Analysis, by Country
13.10. GCC Point-of-Care (POC) Testing Market Forecast, by Product
13.10.1. Glucose Monitoring
13.10.2. Cardiac Markers
13.10.3. Infectious Diseases Testing
13.10.4. Cholesterol Testing
13.10.5. Coagulation Monitoring
13.10.6. Pregnancy And Fertility Testing
13.10.7. Hematology Testing
13.10.8. Blood Gas Testing
13.10.9. Others
13.11. GCC Point-of-Care (POC) Testing Market Forecast, by Application
13.11.1. Clinics
13.11.2. Home Care
13.11.3. Laboratories
13.11.4. Assisted living healthcare facilities
13.11.5. Hospitals
13.12. South Africa Point-of-Care (POC) Testing Market Forecast, by Product
13.12.1. Glucose Monitoring
13.12.2. Cardiac Markers
13.12.3. Infectious Diseases Testing
13.12.4. Cholesterol Testing
13.12.5. Coagulation Monitoring
13.12.6. Pregnancy And Fertility Testing
13.12.7. Hematology Testing
13.12.8. Blood Gas Testing
13.12.9. Others
13.13. South Africa Point-of-Care (POC) Testing Market Forecast, by Application
13.13.1. Clinics
13.13.2. Home Care
13.13.3. Laboratories
13.13.4. Assisted living healthcare facilities
13.13.5. Hospitals
13.14. Rest of Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Product
13.14.1. Glucose Monitoring
13.14.2. Cardiac Markers
13.14.3. Infectious Diseases Testing
13.14.4. Cholesterol Testing
13.14.5. Coagulation Monitoring
13.14.6. Pregnancy And Fertility Testing
13.14.7. Hematology Testing
13.14.8. Blood Gas Testing
13.14.9. Others
13.15. Rest of Middle East & Africa Point-of-Care (POC) Testing Market Forecast, by Application
13.15.1. Clinics
13.15.2. Home Care
13.15.3. Laboratories
13.15.4. Assisted living healthcare facilities
13.15.5. Hospitals
13.16. Middle East & Africa Point-of-Care (POC) Testing Market Attractiveness Analysis
13.16.1. By Product
13.16.2. By Application
13.17. PEST Analysis
13.18. Key Trend
13.19. Key Development
14. South America Point-of-Care (POC) Testing Market Analysis
14.1. Key Findings
14.2. South America Point-of-Care (POC) Testing Market Overview
14.3. South America Point-of-Care (POC) Testing Market Value Share Analysis, by Product
14.4. South America Point-of-Care (POC) Testing Market Forecast, by Product
14.4.1. Glucose Monitoring
14.4.2. Cardiac Markers
14.4.3. Infectious Diseases Testing
14.4.4. Cholesterol Testing
14.4.5. Coagulation Monitoring
14.4.6. Pregnancy And Fertility Testing
14.4.7. Hematology Testing
14.4.8. Blood Gas Testing
14.4.9. Others
14.5. South America Point-of-Care (POC) Testing Market Value Share Analysis, by Application
14.6. South America Point-of-Care (POC) Testing Market Forecast, by Application
14.6.1. Clinics
14.6.2. Home Care
14.6.3. Laboratories
14.6.4. Assisted living healthcare facilities
14.6.5. Hospitals
14.7. South America Point-of-Care (POC) Testing Market Value Share Analysis, by Country
14.8. South America Point-of-Care (POC) Testing Market Forecast, by Country
14.8.1. Brazil
14.8.2. Mexico
14.8.3. Rest of South America
14.9. Brazil Point-of-Care (POC) Testing Market Forecast, by Product
14.9.1. Glucose Monitoring
14.9.2. Cardiac Markers
14.9.3. Infectious Diseases Testing
14.9.4. Cholesterol Testing
14.9.5. Coagulation Monitoring
14.9.6. Pregnancy And Fertility Testing
14.9.7. Hematology Testing
14.9.8. Blood Gas Testing
14.9.9. Others
14.10. Brazil Point-of-Care (POC) Testing Market Forecast, by Application
14.10.1. Clinics
14.10.2. Home Care
14.10.3. Laboratories
14.10.4. Assisted living healthcare facilities
14.10.5. Hospitals
14.11. Mexico Point-of-Care (POC) Testing Market Forecast, by Product
14.11.1. Glucose Monitoring
14.11.2. Cardiac Markers
14.11.3. Infectious Diseases Testing
14.11.4. Cholesterol Testing
14.11.5. Coagulation Monitoring
14.11.6. Pregnancy And Fertility Testing
14.11.7. Hematology Testing
14.11.8. Blood Gas Testing
14.11.9. Others
14.12. Mexico Point-of-Care (POC) Testing Market Forecast, by Application
14.12.1. Clinics
14.12.2. Home Care
14.12.3. Laboratories
14.12.4. Assisted living healthcare facilities
14.12.5. Hospitals
14.13. Rest of South America Point-of-Care (POC) Testing Market Forecast, by Product
14.13.1. Glucose Monitoring
14.13.2. Cardiac Markers
14.13.3. Infectious Diseases Testing
14.13.4. Cholesterol Testing
14.13.5. Coagulation Monitoring
14.13.6. Pregnancy And Fertility Testing
14.13.7. Hematology Testing
14.13.8. Blood Gas Testing
14.13.9. Others
14.14. Rest of South America Point-of-Care (POC) Testing Market Forecast, by Application
14.14.1. Clinics
14.14.2. Home Care
14.14.3. Laboratories
14.14.4. Assisted living healthcare facilities
14.14.5. Hospitals
14.15. South America Point-of-Care (POC) Testing Market Attractiveness Analysis
14.15.1. By Product
14.15.2. By Application
14.16. PEST Analysis
14.17. Key Trend
14.18. Key Development
15. Company Profiles
15.1. Market Share Analysis, by Company
15.2. Competition Matrix
15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
15.2.2. New Product Launches and Product Enhancements
15.2.3. Market Consolidation
15.2.3.1. M&A by Regions, Investment and Applications
15.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
15.3. Company Profiles: Key Players
15.3.1. Abbott
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategy
15.3.1.5. Recent Developments
15.3.1.6. Manufacturing Footprint
15.3.2. Beckman Coulter Inc.
15.3.3. Instrumentation Laboratory
15.3.4. Johnson & Johnson
15.3.5. Nova Biomedical
15.3.6. Qiagen
15.3.7. Roche Diagnostics Limited
15.3.8. Siemens AG
15.3.9. Abaxis, Inc.
15.3.10. Abbott Laboratories
15.3.11. Alfa Scientific Designs, Inc.
15.3.12. ARKRAY, Inc.
15.3.13. Ascencia Diabetes Care Holdings AG
15.3.14. Becton Dickinson and Company
15.3.15. bioMerieux SA
15.3.16. CHEMBIO DIAGNOSTICS, INC.
15.3.17. F. Hoffmann-La Roche AG
15.3.18. LamdaGen Corporation
15.3.19. Medtronic Public Limited Company
15.3.20. Nova Biomedical
16. Primary Key Insights
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
Best quality reports based on various authentic and accurate data findings.
Your personal and confidential information is safe and secure.
Trends Market Research © Copyright 2021. All Rights Reserved.